SEATTLE & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BrainChild Bio, Inc., a clinical-stage biotechnology company developing CAR T-cell therapies to treat tumors in the central nervous system (CNS), today ...
No Messaging, No Camera and Moderated Internet Access Keeps Students On Task and Safe ORLANDO, Fla.--(BUSINESS WIRE)--Schools want to use tablets and handheld devices in the classroom but the dangers ...
Seattle Children's Hospital is spinning out a biotechnology startup named BrainChild Bio to develop new cancer drugs for central nervous system tumors, the hospital announced Tuesday. The company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results